BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 17.6% in December

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 105,961 shares, a drop of 17.6% from the November 30th total of 128,622 shares. Based on an average daily trading volume, of 247,593 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 247,593 shares, the days-to-cover ratio is presently 0.4 days.

Insiders Place Their Bets

In other news, Director Robert W. Fairbairn sold 10,294 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Nova Wealth Management Inc. bought a new stake in shares of BlackRock Health Sciences Term Trust in the first quarter valued at about $39,000. Geneos Wealth Management Inc. bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter valued at approximately $40,000. Allworth Financial LP raised its stake in BlackRock Health Sciences Term Trust by 24,584.6% in the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after buying an additional 3,196 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new position in BlackRock Health Sciences Term Trust in the second quarter worth about $69,000. Finally, Smartleaf Asset Management LLC purchased a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth approximately $91,000.

BlackRock Health Sciences Term Trust Stock Down 0.5%

BlackRock Health Sciences Term Trust stock traded down $0.07 during midday trading on Wednesday, reaching $15.07. 438,164 shares of the company traded hands, compared to its average volume of 304,881. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $16.75. The business has a 50 day moving average of $15.08 and a two-hundred day moving average of $14.60.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Wednesday, December 31st. Shareholders of record on Monday, December 22nd will be given a $0.11 dividend. The ex-dividend date is Monday, December 22nd. This represents a c) annualized dividend and a yield of 8.8%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.